ADVERTISEMENT

404

Not Found

Is this what you were looking for?

tag tick born disease developmental biology ecology culture

A close up of a tick held in a pair of forceps, with Kevin Esvelt’s face out of focus in the background.
CRISPR Gene Drives and the Future of Evolution
Hannah Thomasy, PhD | Mar 15, 2024 | 10+ min read
Genetic engineering pioneer Kevin Esvelt’s work highlights biotechnology’s immense potential for good—but also for catastrophe.
Trouble in the Heartland
Jef Akst | Oct 1, 2013 | 4 min read
A new tick-borne disease has emerged in the US Midwest—and the culprit is not a bacterium. 
Researchers Finding Rewarding Careers As Software Entrepreneurs
Karen Hopkin | Jul 7, 1996 | 10 min read
Bacterium SIZE MATTERS: Deer ticks -- vectors of Borrelia Burgdorferi -- are half the size of the common dog tick, which is not associated with Lyme disease. As a new generation of adolescent deer tick enjoys its first blood meal, scientists in the United States and abroad continue to focus their research efforts on understanding and preventing Lyme disease. Ticks infected with the bacterium Borrelia burgdorferi cause more than 10,000 cases of Lyme disease in the U.S. each year, according to
Guts and Glory
Anna Azvolinsky | Apr 1, 2016 | 9 min read
An open mind and collaborative spirit have taken Hans Clevers on a journey from medicine to developmental biology, gastroenterology, cancer, and stem cells.
Monoclonal Antibodies Find Utility In Cell Biology
Ricki Lewis | Dec 11, 1994 | 10+ min read
But, just as antibodies are finding increasing utility in cell biology, a new Food and Drug Administration classification for those products with clinical utility may affect researchers' access to the important technology (see accompanying story). Monoclonal History MAbs were born in 1975, when Georges Kohler and Cesar Milstein at the Medical Research Council Laboratories in Cambridge, England, fused two types of cells to form a hy
Monoclonal Antibodies Find Utility In Cell Biology
Ricki Lewis | Dec 11, 1994 | 10+ min read
But, just as antibodies are finding increasing utility in cell biology, a new Food and Drug Administration classification for those products with clinical utility may affect researchers' access to the important technology (see accompanying story). Monoclonal History MAbs were born in 1975, when Georges Kohler and Cesar Milstein at the Medical Research Council Laboratories in Cambridge, England, fused two types of cells to form a hy
An illustration of green bacteria floating above neutral-colored intestinal villi
The Inside Guide: The Gut Microbiome’s Role in Host Evolution
Catherine Offord | Jul 1, 2021 | 10+ min read
Bacteria that live in the digestive tracts of animals may influence the adaptive trajectories of their hosts.
On the Fast Track in Functional Proteomics
A. J. S. Rayl | Apr 1, 2001 | 8 min read
Graphic: Leza Berardone Researchers in Canada and Denmark are employing mass spectrometry, three-dimensional tissue biology, and supercomputing to blaze a trail in functional proteomics research. In the process, they're putting their company, MDS Proteomics Inc., on the fast track in the latest race to develop new drug targets and eventually better treatments for all kinds of diseases. By using this combination of technologies, MDS Proteomics is accelerating the process of identifying, analyzin
They came from above
Brendan Borrell | Dec 1, 2008 | 6 min read
They came from above All photos by Brendan Borrell Opportunistic infections seem to pop up out of nowhere, but new strains are appearing in new places, striking otherwise healthy animals - including humans. A few microbiologists go hunting. By Brendan Borrell n the spring of 2000, veterinarian Craig Stephen walked up to the biology department at Vancouver Island University in Nanaimo for what he thought would be a routine autopsy of a dead
Contributors
Amanda B. Keener | Aug 1, 2015 | 3 min read
Meet some of the people featured in the August 2015 issue of The Scientist.

Run a Search

ADVERTISEMENT